PHBI — Pharmagreen Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- $0.53m
- $0.88m
Annual cashflow statement for Pharmagreen Biotech, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2018 September 30th | 2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.07 | -0.769 | -2.44 | -4.53 | -0.876 |
| Non-Cash Items | 0.325 | 0.295 | 1.94 | 4.42 | 0.206 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.037 | 0.156 | -0.108 | -0.09 | 0.243 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.786 | -0.318 | -0.608 | -0.206 | -0.427 |
| Capital Expenditures | -0.251 | -0.196 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.251 | -0.196 | 0 | — | — |
| Financing Cash Flow Items | 0.824 | 0.358 | -0.077 | -0.01 | 0.097 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.12 | 0.433 | 0.563 | 0.258 | 0.314 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.135 | -0.089 | -0.05 | 0.013 | -0.017 |